Radiology · 510(k) · 2021
Auto Lung Nodule Detection
Samsung Electronics Co.,Ltd.. Cleared by FDA on 31 August 2021 under submission K201560, product code MYN (analyzer, medical image). What FDA's record says, in FDA's words.
Device record · K201560
- Device. Auto Lung Nodule DetectionDEVICE
- Company. Samsung Electronics Co.,Ltd. (KR)COMPANY
- Decision. 31 August 2021, 510(k), substantially equivalent (traditional review); received 10 June 2020DECISION
- Panel. RadiologyPANEL
- Product code. MYN, Analyzer, Medical ImageCODE
- Regulation. 21 CFR 892.2070, Class IIREG
- Source. FDA database entry · decision document (8 pages)SOURCE
Retrieved · the fields above are FDA's; the statement below was copied from the decision document on that day.
What FDA cleared it for
The Indications for Use statement, verbatim, from the decision document.
The Auto Lung Nodule Detection is computer-aided detection software to identify and mark regions in relation to suspected pulmonary nodules from 10 to 30 mm in size. It is designed to aid the physician to review the PA chest radiographs of adults as a second reader and be used as part of S-Station, which is operation software installed on Samsung Digital X-ray Imaging systems. Auto Lung Nodule Detection cannot be used on the patients who have lung lesions other than abnormal nodules.
The product code's definition, from FDA's classification record. For information on the MYN device, please see: https://www.federalregister.gov/documents/2020/01/22/2020-00494/radiology-devices-reclassification-of-medical-image-analyzers
What the statement says
Pattern matches on the Indications for Use text. Each line is a fact that the text contains the words, not a finding about the device.
- Modalities namedradiographs (X-ray)
- Mentionsan adjunct to the clinician, not a replacement
- Mentionsdetection or identification of findings
- Mentionsadult patients
Adverse-event reports in MAUDE, by product code
As of , MAUDE held 5 reports filed against devices carrying product code MYN. That code is shared by every device of this type, not this device alone, and MAUDE reports are submitted by manufacturers, facilities and the public without FDA verification. The latest reports, in the reporter’s words:
13 March 2025 · Injury · SECOND OPINION · PEARL INC. · report MW5167620
DEAR FDA MEDWATCH, I AM REPORTING A SERIOUS ISSUE REGARDING PLANET DDS'S INTEGRATION OF PEARL AI ASSIST IN DENTICON PMS AND XVWEB IMAGING SYSTEM, WHICH LED TO AN INACCURATE TREATMENT RECOMMENDATION AND INABILITY TO CORRECT AI FINDINGS. WHAT HAPPENED I RECENTLY VISITED A DENTAL CLINIC THAT USES DENTICON PMS WITH PEARL AI ASSIST. BEFORE REVIEWING MY DENTAL IMAGES, THE DENTIST RECOMMENDED AN ENDODONTIC PROCEDURE BASED ON AI FINDINGS DISPLAYED IN DENTICON. AI SUGGESTED DECAY AND A PERIAPICAL […]
18 February 2025 · Malfunction · OVERJET CARIES ASSIST · OVERJET · report MW5166306
THE 510(K) SUBSTANTIAL EQUIVALENCE REPORT FOR OVERJET CARIES ASSIST (K212519) SHOWS SENSITIVITY AND SPECIFICITY OF 72.0% AND 98.1%, RESPECTIVELY, FOR CARIES DETECTION. HOWEVER, CALCULATIONS BASED ON THE TABLE IN SECTION 10 REVEAL A POSITIVE PREDICTIVE VALUE OF ONLY 57.2%. THIS MEANS THAT 42.8% OF OBSERVED CARIES BY THE OVERJET PRODUCT WERE NOT ACTUALLY CARIES ACCORDING TO GROUND TRUTH. SUCH A HIGH RATE OF FALSE POSITIVES HAS THE POTENTIAL TO RESULT IN OVER-TREATMENT DUE TO FALSELY IDENTIFYING […]
15 April 2024 · Malfunction · PEARL SECOND OPINION · PEARL INC. · report MW5153880
HELLO, I AM WRITING TO EXPRESS SIGNIFICANT CONCERNS REGARDING THE COMPLIANCE AND MARKETING PRACTICES OF PEARL, PARTICULARLY RELATED TO THEIR DENTAL DIAGNOSTIC TOOLS. OUR EXPECTATIONS WERE THAT PEARL'S FDA CLEARED MEDICAL DEVICE ((B)(6)) WOULD ADHERE TO THE HIGHEST STANDARDS OF REGULATORY COMPLIANCE, ESPECIALLY GIVEN THE CRITICAL NATURE OF DENTAL HEALTH DIAGNOSTICS. HOWEVER, IT APPEARS THERE ARE CRUCIAL AREAS WHERE PEARL'S OFFERINGS MAY NOT ALIGN WITH REGULATORY GUIDELINES AND DO NOT ALIGN WITH […]
11 January 2018 · Malfunction · POWERLOOK AMP WITH SECONDLOOK DIGITAL GE · ICAD, INCORPORATED · report 1225671-2018-00001
A CUSTOMER SITE INDICATED THAT NO CAD MARKINGS WERE REPORTED FROM THE CAD AFTER PROCESSING PATIENT IMAGES. THE OEM MAMMOGRAPHY FIELD SERVICE ENGINEER (FSE) DID NOT APPLY THE CAD LICENSE AFTER INSTALLING THE CAD SOFTWARE. THIS RESULTED IN THE SITE NOT HAVING CAD MARKS ON CASES FOR SOME TIME. NO PATIENT INJURY OR ADVERSE EVENT WAS ASSOCIATED WITH THIS INCIDENT.
18 May 2006 · Malfunction · RAPIDSCREEN RS-2000D AND RS-DIGITAL · RIVERAIN MEDICAL · report 3005156333-2006-00001
ON APRIL 24, 2006, A CONTROL FILE ERROR WITH RESPECT TO THE RAPIDSCREEN RS-2000D AND RS-DIGITAL DEVICE WAS DISCOVERED DURING A CLINICAL STUDY BEING CONDUCTED FOR A PMA SUPPLEMENTAL SUBMISSION. THE CONTROL FILE ERROR RESULTS IN SENSITIVITY AND SPECIFICITY THAT DIFFER FROM THE PMA-APPROVED PRODUCT SPECIFICATIONS FOR THE DEVICE. SPECIFICALLY, THE PRODUCT THAT WAS PLACED INTO COMMERCIAL DISTRIBUTION HAS A SENSITIVITY OF 57% AND A SPECIFICITY OF 3.97 (FALSE POSITIVES PER IMAGE), WHICH DIFFERS FROM […]
Where this fits
This page is a record, not medical advice and not a safety rating. It copies FDA's fields and FDA's statement, and lists what the statement's text mentions. Read the labeling before relying on any of it.
More devices under product code MYN, in Radiology, from Samsung Electronics Co.,Ltd., or cleared in 2021. The whole record is at FDA AI-enabled medical devices.
A device's authorized use is a sentence the record can be read against. What Apodicta does on a medical record is that reading: every line of a note, a claim or a report proved to its source or held, before it renders.